Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Mikhail Statsenko"'
Publikováno v:
Терапевтический архив, Vol 86, Iss 1, Pp 54-59 (2014)
Scopus-Elsevier
ResearcherID
Scopus-Elsevier
ResearcherID
AIM: To evaluate the anti-ischemic and anti-anginal efficacy of meldonium (Idrinol) in its short-term use as part of combination therapy in patients with chronic heart failure in the early post-infarction period/MATERIAL AND METHODS: The investigatio
Autor:
Mariana Gospodinova, Francesc Formiga, Miguel-Ángel Idoate-Gastearena, Jose Nicolau, Oksana Drapkina, Winston Bonetti Yoshida, Arintaya Phrommintikul, JIANN-SHING JENG, Thomas Frieden, Vladimir Shulman, Yook-Chin Chia, Christopher Chen, Shaiful bahari Ismail, DIMITRIOS PARISSIS, Vicente Climent, John Cooke, Tomás Segura, Enrique Rodilla, Andrey Komarov, Joseph Eickmeyer, Prof Prakash P Punjabi, Yury Grinshtein, Martin James, Muriel Sprynger, Raymond Seet, Dragos Catalin Jianu, Ricardo Mourilhe-Rocha, Chaicharn Deerochanawong, Ru San Tan, Zhanna D. Kobalava, ALVARO AVEZUM, Monica Acevedo, Prof. Abdulhalim Kinsara, Iana Orlova, Maria Teresa Zanella, ELENA BOBESCU, Vijay Sharma, Veronika Lopukhova, Catalin Adrian Buzea, Yuri Karpov, Philippe Gabriel STEG, Stephen Hillis, Ali Azman Raymond, Jonathan Maltz, Albert Galyavich, Yomar Gonzalez, Hamidon Basri, Jeong-Taek Woo, Sung-Chun Tang, Ivo Petrov, Chirk Jenn Ng, TZUNG-DAU WANG, Sergei Shalaev, Marine Tanashyan, Gyorgy Gergely, Michael Lim, Mary Joan Macleod, Raffaella Pisapia, Jean Ferrieres, Alexander Nikonenko, Viktor Tashchuk, Jean-Luc Reny, Lea Maciel, Oleg Rodnenkov, Rodica Balasa, Farzanna Haffizulla, Mikhail Statsenko, Liviu Macovei, Albert Vernon Smith, Snezhanka Tisheva, Maria Glezer, Ji Hoe Heo, Umayya Musharrafieh, Emilian Bogdan Ignat, Teguh Santoso, John Malcolm Walker, Iurii Rudyk, Kyong Soo Park, Arman Postadzhiyan, Antonio Arauz, Veeda michelle Anlacan
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Background The extent to which angina is associated with future cardiovascular events in patients with coronary artery disease has long been debated. Methods and Results Included were outpatients with established coronary artery disease who were enro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b880310db324a822121314e1e62ff809
http://hdl.handle.net/10044/1/51609
http://hdl.handle.net/10044/1/51609
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 5, Pp 40-46 (2011)
Scopus-Elsevier
ResearcherID
Scopus-Elsevier
ResearcherID
Autor:
Mikhail Statsenko, Nedogoda, S. V., Turkina, S. V., Tyshchenko, I. A., Poletaeva, L. V., Chumachok, E. V., Ledyaeva, A. A., Tsoma, V. V.
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 4, Pp 91-95 (2011)
Scopus-Elsevier
ResearcherID
Scopus-Elsevier
ResearcherID
The study aimed to assess the effects of long-term and course mildronate therapy (500 mg/d) on cognitive function in elderly patients with arterial hypertension (AH) and cognitive dysfunction. This open, randomised, controlled comparative study in pa
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 2, Pp 102-110 (2011)
ResearcherID
ResearcherID
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 6, Pp 28-33 (2010)
ResearcherID
ResearcherID
The study included 60 patients, aged 45-65 years, with metabolic syndrome (MS), Functional Class II-III chronic heart failure (CHF), and recent myocardial infarction (MI). The participants were randomised into 2 groups (n=30 in each). The main group
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 6, Pp 49-55 (2009)
ResearcherID
ResearcherID
In total, the study included 60 45-64-year-old patients in early post-infarction phase, with chronic heart failure (CHF), Functional Class II-III, and metabolic syndrome (MS). The patients were randomised into two groups (n=30 in each group). In the
Beta-adrenoЬlockers in patients with chronic heart failure and chronic obstructive pulmonary disease
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 7, Iss 8, Pp 58-63 (2008)
ResearcherID
ResearcherID
Aim. To compare clinical effectiveness and safety of bisoprolol and metoprolol as a part of basis chronic heart failure (CHF) therapy in patients with coexisting chronic obstructive pulmonary disease (COPD).Material and methods. The study included 60
Autor:
Mikhail Statsenko, Shcherbakova, T. G., Sporova, O. E., Belenkova, S. V., Kalashnikova, Yu V.
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 6, Pp 27-32 (2008)
ResearcherID
Scopus-Elsevier
ResearcherID
Scopus-Elsevier
Six-month indapamide therapy was highly effective in 70 % of elderly patients with Stage I-II arterial hypertension (AH). In 30 %, a combination of indapamide with lisinopril was necessary for achieving target blood pressure (BP) levels. Indapamide t
Autor:
Jose Nicolau, Victor Aboyans, Robert Storey, Jacek Kubica, Miguel Urina, Thomas Muenzel, Andrzej Lubiński, Peter Sinnaeve, ELENA BOBESCU, Antonio Fernandez-Ortiz, Ahmed Abdel-Latif, GABRIELA CIOCA, Bassem A. Samad, Philippe Gabriel STEG, Richard Nethononda, Lesia Rasputina, Murat Kazim Ersanli, Mariya Derevyanchenko, Arie Van Dijk, Sergey Nedogoda, Silvia Valbuena-Lopez, Fernando Lanas, Tomas Janota, Bas Kietselaer, Meyer ELBAZ, Eduardo Costa Duarte Barbosa, R. David Anderson, Piotr Ponikowski, Mara Rubino, Diego Rizzotti, Andriy Bazylevych, Maya Safarova, Mikhail Statsenko, Giuseppe Patti, Fernando Manzur, Sergey Golitsyn, Larisa Yena, William Wijns, Andrzej Budaj
Publikováno v:
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2015, 372 (19), pp.1791-1800. ⟨10.1056/NEJMoa1500857⟩
The New England journal of medicine
New England Journal of Medicine, Massachusetts Medical Society, 2015, 372 (19), pp.1791-1800. ⟨10.1056/NEJMoa1500857⟩
The New England journal of medicine
International audience; BACKGROUND:The potential benefit of dual antiplatelet therapy beyond 1 year after a myocardial infarction has not been established. We investigated the efficacy and safety of ticagrelor, a P2Y12 receptor antagonist with establ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb3e1405e855c1d5a47edfa42b1cd87a
https://hal.archives-ouvertes.fr/hal-01934996
https://hal.archives-ouvertes.fr/hal-01934996